Association between glycosylated haemoglobin A1c and endothelial function in an adult non-diabetic population

Atherosclerosis

Volumn 217, Issue 2, 2011, Pages 358-363

  Lorbeer, Roberto ^a   Empen, Klaus ^a   Dörr, Marcus ^a   Arndt, Maria ^a   Schipf, Sabine ^a   Nauck, Matthias ^a   Wallaschofski, Henri ^a   Felix, Stephan B ^a   Völzke, Henry ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Endothelial function; HbA1c; Study of Health in Pomerania

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATION; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NITRATE MEDIATED DILATION; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING; ULTRASOUND; VASODILATATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; GERMANY; GLUCOSE METABOLISM DISORDERS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPEREMIA; LINEAR MODELS; MALE; MIDDLE AGED; NITROGLYCERIN; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; UP-REGULATION; VASODILATION; VASODILATOR AGENTS;

EID: 79960700153     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.04.007     Document Type: Article

References (28)

1. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002, 39:257-265.
2. Tousoulis D., Antoniades C., Stefanadis C. Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart 2005, 91:553-558.
3. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23:168-175.
4. Yeboah J., Folsom A.R., Burke G.L., et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009, 120:502-509.
5. Benjamin E.J., Larson M.G., Keyes M.J., et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham heart study. Circulation 2004, 109:613-619.
6. Simons L.A., Sullivan D., Simons J., Celermajer D.S. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. Atherosclerosis 1998, 137:197-203.
7. Celermajer D.S., Sorensen K.E., Georgakopoulos D., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993, 88:2149-2155.
8. Henry R.M., Ferreira I., Kostense P.J., et al. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; the Hoorn study. Atherosclerosis 2004, 174:49-56.
9. International expert committee report on the role of the a1c assay in the diagnosis of diabetes. Diabetes Care 2009, (32):1327-1334.
10. Little R.R., Sacks D.B. Hba1c: how do we measure it and what does it mean?. Curr Opin Endocrinol Diabetes Obes 2009, 16:113-118.
11. Nathan D.M., Buse J.B., Davidson M.B., et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care 2009, 32:193-203.
12. Selvin E., Steffes M.W., Zhu H., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811.
13. Thomas G.N., Chook P., Qiao M., et al. Deleterious impact of "High normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the Cathay study. Arterioscler Thromb Vasc Biol 2004, 24:739-743.
14. Voidonikola P.T., Stamatelopoulos K.S., Alevizaki M., et al. The association between glycemia and endothelial function in nondiabetic individuals: the importance of body weight. Obesity (Silver Spring) 2008, 16:2658-2662.
15. Volzke H., Alte D., Schmidt C.O., et al. Cohort profile: the study of health in pomerania. Int J Epidemiol. 2011, 40:294-307.
16. Guidelines for ATC classification and DDD assignment 2011 2010, WHO Collaborating Centre for Drug Statistics Methodology, Oslo.
17. Haring R., Volzke H., Felix S.B., et al. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 2009, 58:2027-2031.
18. Volzke H., Robinson D.M., Spielhagen T., et al. Are serum thyrotropin levels within the reference range associated with endothelial function?. Eur Heart J 2009, 30:217-224.
19. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the jnc 7 report. JAMA 2003, 289:2560-2572.
20. Nadar S., Blann A.D., Lip G.Y. Antihypertensive therapy and endothelial function. Curr Pharm Des 2004, 10:3607-3614.
21. Ghiadoni L., Magagna A., Kardasz I., Taddei S., Salvetti A. Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am J Hypertens 2009, 22:506-512.
22. Pasini A.F., Garbin U., Nava M.C., et al. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients. Am J Hypertens 2007, 20:443-450.
23. Buus N.H., Jorgensen C.G., Mulvany M.J., Sorensen K.E. Large and small artery endothelial function in patients with essential hypertension - effect of ace inhibition and beta-blockade. Blood Press 2007, 16:106-113.
24. Forte P., Kneale B.J., Milne E., et al. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 1998, 32:730-734.
25. Patel P.D., Arora R.R. Endothelial dysfunction: a potential tool in gender related cardiovascular disease. Ther Adv Cardiovasc Dis 2008, 2:89-100.
26. Moebus S., Stang A., Mohlenkamp S., et al. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort - results of the Heinz Nixdorf recall study. Diabetologia 2009, 52:81-89.
27. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
28. Weiss E.P., Arif H., Villareal D.T., Marzetti E., Holloszy J.O. Endothelial function after high-sugar-food ingestion improves with endurance exercise performed on the previous day. Am J Clin Nutr 2008, 88:51-57.